RWA
NVCR icon

Redhawk Wealth Advisors’s NovoCure NVCR Stock Holding History

Redhawk Wealth Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,749
Closed -$454K – 190
2020
Q1 		$454K Sell
6,749
-1,367
-17% -$108K 0.2% 84
2019
Q4 		$684K Sell
8,116
-590
-7% -$47.6K 0.26% 57
2019
Q3 		$651K Buy
8,706
+309
+4% +$24.7K 0.28% 53
2019
Q2 		$531K Buy
+8,397
New +$425K 0.21% 69

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Redhawk Wealth Advisors's NVCR Position: Q2 2020 in Review

Redhawk Wealth Advisors sold out of NovoCure (NVCR) in Q2 2020, closing a stake of 6,749 shares — an estimated $454K sold.

Redhawk Wealth Advisors first reported a position in NVCR in Q2 2019 and held it in 4 quarters. The position peaked at $684K in Q4 2019. 264 funds tracked by Wall St. Rank hold NVCR as of Q2 2020.

  • Redhawk Wealth Advisors reported no remaining NovoCure position as of Q2 2020 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 6,749 NovoCure shares in Q2 2020, an estimated $454K.
  • Redhawk Wealth Advisors first reported a position in NovoCure in Q2 2019 and held it in 4 quarters.
  • Redhawk Wealth Advisors's NovoCure position peaked at $684K in Q4 2019.
  • 264 funds tracked by Wall St. Rank held NovoCure as of Q2 2020.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2020, filed 14 Jul 2020.